Ariyapadi has more than 30 years of commercialization experience in the pharmaceutical and biotech industry.
Prior to joining Atea, Ariyapadi was President of Mailams Strategy Advisors, a pharmaceutical consulting firm providing commercialization services. Prior to founding the firm, he was Senior Vice President of Marketing and Market Access at Iroko Pharmaceuticals. Before that, Ariyapadi was Vice President of Marketing at Novartis Vaccines and Diagnostics. Earlier, Ariyapadi served in roles of increasing responsibility at GlaxoSmithKline, most recently as Executive Director of Marketing of the Anti-Infective Franchise.
Ariyapadi holds a BS in Biology from the University of Madras, a Master’s in International Management from International Management Institute of New Delhi and an MBA from the State University of New York at Buffalo.Back to Full Team